XANTHOPOULOS KLEANTHIS GABRIEL

PrivateCIK: 2115875
Location

SAN DIEGO, CA

XANTHOPOULOS KLEANTHIS GABRIEL enters CONNECT BIOPHARMA HOLDINGS LTD with 80K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
Director
Since Mar 2026
80K
Baseline shares
100% direct
80K
Direct ownership
1 position
338.90K
Derivative underlying
7 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Ordinary Shares

Direct
Shares owned80K
Total
80K direct80K
Derivative Holdings7

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

28.36K

Shares owned

N/A

Exercise price

1.27

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

21.27K

Shares owned

N/A

Exercise price

4.12

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

60K

Shares owned

N/A

Exercise price

2.50

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

89.22K

Shares owned

N/A

Exercise price

8.16

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

60K

Shares owned

N/A

Exercise price

0.96

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

46.51K

Shares owned

N/A

Exercise price

1.04

Expiration

Exercise window

Stock Option (Right to Buy)

Direct
Underlying security
Ordinary Shares

Underlying shares

33.54K

Shares owned

N/A

Exercise price

1.18

Expiration

Exercise window

Total

Underlying

338.90K

Owned

0.00

XANTHOPOULOS KLEANTHIS GABRIEL — Initial Ownership Disclosure (Form 3) Filed Mar 16, 2026 | Finecho